• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与无损伤进展相关的类风湿性关节炎磁共振成像炎症阈值的开发与验证

Development and validation of rheumatoid arthritis magnetic resonance imaging inflammation thresholds associated with lack of damage progression.

作者信息

Baker Joshua F, Østergaard Mikkel, Emery Paul, Baker Daniel G, Conaghan Philip G

机构信息

Philadelphia Veterans Affairs Medical Center; University of Pennsylvania, School of Medicine; and Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, USA.

Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup; and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.

出版信息

Clin Exp Rheumatol. 2017 Jul-Aug;35(4):607-613. Epub 2017 Jan 27.

PMID:28134079
Abstract

OBJECTIVES

To determine thresholds for rheumatoid arthritis (RA) magnetic resonance imaging scores (RAMRIS) associated with a low risk of structural damage progression.

METHODS

MRI of the dominant hand was performed and RAMRIS scores determined at weeks 0, 24, and 52. X-rays were performed and van der Heijde-Sharp scores (vdHS) determined. In a development cohort (n=297) the changes in MRI erosion score and vdHS score were determined over the 24-week to 52-week interval and progression was defined as change >0.5. We identified 24-week thresholds for synovitis and osteitis that provided >90% sensitivity for imaging progression over the 24 to 52-week interval. The performance of these cut-offs was tested in a validation cohort (n=217).

RESULTS

In the development cohort, synovitis or osteitis scores ≤3 by 24 weeks were associated with a low probability of progression on MRI and x-ray. The coefficient for osteitis was stronger than that of synovitis in models predicting x-ray and MRI progression. Therefore, a total inflammation score was weighted on osteitis (x2). An inflammation score ≤9 was more frequently attained than DAS28 remission (64 vs. 38) and was associated with low probability of progression regardless of attainment of clinical remission. In the validation cohort, there was a low odds of MRI progression among those with low synovitis [OR 0.27 (0.086,0.82) p=0.02], osteitis [OR 0.20 (0.085, 0.49) p<0.001] and inflammation scores [OR 0.12 (0.033, 0.41) p=0.001].

CONCLUSIONS

Attainment of low MRI single-hand synovitis and osteitis is not uncommon and predicts a lack of structural progression in RA, independent of clinical remission.

摘要

目的

确定与结构损伤进展低风险相关的类风湿性关节炎(RA)磁共振成像评分(RAMRIS)阈值。

方法

对优势手进行MRI检查,并在第0、24和52周确定RAMRIS评分。进行X线检查并确定范德海伊德-夏普评分(vdHS)。在一个开发队列(n = 297)中,确定24周龄至52周龄期间MRI侵蚀评分和vdHS评分的变化,并将进展定义为变化>0.5。我们确定了滑膜炎和骨炎的24周阈值,这些阈值在24至52周期间对成像进展的敏感性>90%。在一个验证队列(n = 217)中测试了这些临界值的性能。

结果

在开发队列中,到24周时滑膜炎或骨炎评分≤3与MRI和X线进展的低概率相关。在预测X线和MRI进展的模型中,骨炎的系数比滑膜炎的系数更强。因此,总炎症评分以骨炎为权重(x2)。炎症评分≤9比DAS28缓解更常见(64比38),并且与进展的低概率相关,无论是否达到临床缓解。在验证队列中,滑膜炎[比值比0.27(0.086,0.82)p = 0.02]、骨炎[比值比0.20(0.085,0.49)p<0.001]和炎症评分[比值比0.12(0.033,0.41)p = 0.001]较低的患者中MRI进展的几率较低。

结论

单手MRI滑膜炎和骨炎程度低并不罕见,且可预测RA中结构进展的缺乏,与临床缓解无关。

相似文献

1
Development and validation of rheumatoid arthritis magnetic resonance imaging inflammation thresholds associated with lack of damage progression.与无损伤进展相关的类风湿性关节炎磁共振成像炎症阈值的开发与验证
Clin Exp Rheumatol. 2017 Jul-Aug;35(4):607-613. Epub 2017 Jan 27.
2
Magnetic Resonance Imaging of Bilateral Hands Is More Optimal Than MRI of Unilateral Hands for Rheumatoid Arthritis.双手磁共振成像比单侧手磁共振成像更有利于类风湿关节炎。
J Rheumatol. 2018 Jul;45(7):895-904. doi: 10.3899/jrheum.171044. Epub 2018 May 1.
3
Validity of early MRI structural damage end points and potential impact on clinical trial design in rheumatoid arthritis.类风湿关节炎早期MRI结构损伤终点的有效性及其对临床试验设计的潜在影响。
Ann Rheum Dis. 2016 Jun;75(6):1114-9. doi: 10.1136/annrheumdis-2014-206934. Epub 2015 Jun 19.
4
Efficacy of abatacept in patients with rheumatoid arthritis, as assessed by magnetic resonance imaging of bilateral hands.通过双手磁共振成像评估阿巴西普对类风湿关节炎患者的疗效。
Int J Rheum Dis. 2018 Sep;21(9):1678-1685. doi: 10.1111/1756-185X.13135. Epub 2017 Jul 21.
5
Relationship of patient-reported outcomes with MRI measures in rheumatoid arthritis.类风湿关节炎患者报告结局与 MRI 测量的相关性。
Ann Rheum Dis. 2017 Mar;76(3):486-490. doi: 10.1136/annrheumdis-2016-209463. Epub 2016 Jul 18.
6
ACR/EULAR Definitions of Remission Are Associated with Lower Residual Inflammatory Activity Compared with DAS28 Remission on Hand MRI in Rheumatoid Arthritis.与类风湿关节炎手部MRI的DAS28缓解相比,美国风湿病学会/欧洲抗风湿病联盟(ACR/EULAR)的缓解定义与更低的残余炎症活动相关。
J Rheumatol. 2016 Sep;43(9):1631-6. doi: 10.3899/jrheum.150849. Epub 2016 Jul 1.
7
Magnetic resonance imaging assessed inflammation in the wrist is associated with patient-reported physical impairment, global assessment of disease activity and pain in early rheumatoid arthritis: longitudinal results from two randomised controlled trials.磁共振成像评估腕关节炎症与早期类风湿关节炎患者报告的身体功能障碍、疾病活动的整体评估和疼痛相关:两项随机对照试验的纵向结果。
Ann Rheum Dis. 2017 Oct;76(10):1707-1715. doi: 10.1136/annrheumdis-2017-211315. Epub 2017 Jun 13.
8
Determining MRI Inflammation Targets When Considering a Rheumatoid Arthritis Treat-to-Target Strategy: Results of a Randomized, Placebo-Controlled Trial.考虑类风湿关节炎治疗目标策略时确定 MRI 炎症靶点:一项随机、安慰剂对照试验的结果。
Adv Ther. 2019 Sep;36(9):2384-2393. doi: 10.1007/s12325-019-01020-6. Epub 2019 Jul 5.
9
Obesity and rates of clinical remission and low MRI inflammation in rheumatoid arthritis.肥胖与类风湿关节炎的临床缓解率和低 MRI 炎症率。
Ann Rheum Dis. 2017 Oct;76(10):1743-1746. doi: 10.1136/annrheumdis-2017-211569. Epub 2017 Jun 12.
10
The effects of tocilizumab on osteitis, synovitis and erosion progression in rheumatoid arthritis: results from the ACT-RAY MRI substudy.托珠单抗对类风湿关节炎骨炎、滑膜炎和侵蚀进展的影响:来自 ACT-RAY MRI 子研究的结果。
Ann Rheum Dis. 2014 May;73(5):810-6. doi: 10.1136/annrheumdis-2013-204762. Epub 2014 Feb 13.

引用本文的文献

1
Prediction of flare following remission and treatment withdrawal in early rheumatoid arthritis: post hoc analysis of a phase IIIb trial with abatacept.早期类风湿关节炎缓解后和停药时的 flares 预测:阿巴西普治疗 IIIb 期临床试验的事后分析。
Arthritis Res Ther. 2022 Feb 16;24(1):47. doi: 10.1186/s13075-022-02735-8.
2
Rheumatoid Arthritis Relapse and Remission - Advancing Our Predictive Capability Using Modern Imaging.类风湿关节炎的复发与缓解——利用现代影像学提升我们的预测能力
J Inflamm Res. 2021 Jun 16;14:2547-2555. doi: 10.2147/JIR.S284405. eCollection 2021.
3
Baseline Objective Inflammation by Magnetic Resonance Imaging as a Predictor of Therapeutic Benefit in Early Rheumatoid Arthritis With Poor Prognosis.
磁共振成像检测的基线客观炎症作为早期类风湿关节炎预后不良患者治疗获益预测指标的研究
Arthritis Care Res (Hoboken). 2020 Jul;72(7):959-964. doi: 10.1002/acr.24072. Epub 2020 May 26.
4
Determining MRI Inflammation Targets When Considering a Rheumatoid Arthritis Treat-to-Target Strategy: Results of a Randomized, Placebo-Controlled Trial.考虑类风湿关节炎治疗目标策略时确定 MRI 炎症靶点:一项随机、安慰剂对照试验的结果。
Adv Ther. 2019 Sep;36(9):2384-2393. doi: 10.1007/s12325-019-01020-6. Epub 2019 Jul 5.
5
Sex Differences in the Achievement of Remission and Low Disease Activity in Rheumatoid Arthritis.类风湿关节炎缓解和低疾病活动度的实现中的性别差异。
Arthritis Care Res (Hoboken). 2020 Mar;72(3):326-333. doi: 10.1002/acr.23873.
6
Imaging in rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, and osteoarthritis: An international viewpoint on the current knowledge and future research priorities.类风湿关节炎、银屑病关节炎、中轴型脊柱关节炎和骨关节炎的影像学:关于当前知识及未来研究重点的国际视角
Eur J Rheumatol. 2019 Jan;6(1):38-47. doi: 10.5152/eurjrheum.2018.18121.
7
Clinical, Imaging, and Pathological Suppression of Synovitis in Rheumatoid Arthritis: Is the Disease Curable?类风湿关节炎滑膜炎的临床、影像学及病理抑制:该病可治愈吗?
Front Med (Lausanne). 2018 May 15;5:140. doi: 10.3389/fmed.2018.00140. eCollection 2018.